BR0212574A - Método de purificação de polipeptìdeo - Google Patents

Método de purificação de polipeptìdeo

Info

Publication number
BR0212574A
BR0212574A BR0212574-9A BR0212574A BR0212574A BR 0212574 A BR0212574 A BR 0212574A BR 0212574 A BR0212574 A BR 0212574A BR 0212574 A BR0212574 A BR 0212574A
Authority
BR
Brazil
Prior art keywords
tyrosine kinase
kinase receptor
polypeptide
purification method
expressed
Prior art date
Application number
BR0212574-9A
Other languages
English (en)
Inventor
David Dawbarn
Shelley Jane Allen
Alan George Simpson Robertson
Original Assignee
Univ Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bristol filed Critical Univ Bristol
Publication of BR0212574A publication Critical patent/BR0212574A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"MéTODO DE PURIFICAçãO DE POLIPEPTìDEO". A presente invenção refere-se a um método de purificação, particularmente para purificar polipeptídeos relacionados ao receptor de cinase de tirosina e aos produtos feitos pelo método. O método compreende um método de produzir polipeptídeos relacionados ao receptor de cinase de tirosina, o método compreendendo expressar o polipeptídeo relacionado ao receptor de cinase de tirosina em um sistema de expressão recombinante e separar o polipeptídeo relacionado ao receptor de cinase de tirosina, monomérico, expresso, da(s) forma(s) multimérica(s) do polipeptídeo, expresso, em uma etapa de separação, a etapa de separação permitindo a redobragem do polipeptídeo relacionado ao receptor de cinase de tirosina, expresso, em uma forma biologicamente ativa.
BR0212574-9A 2001-09-17 2002-09-17 Método de purificação de polipeptìdeo BR0212574A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0122400.5A GB0122400D0 (en) 2001-09-17 2001-09-17 Polypeptide purification method
PCT/GB2002/004214 WO2003025016A2 (en) 2001-09-17 2002-09-17 Trk polypeptide purification method

Publications (1)

Publication Number Publication Date
BR0212574A true BR0212574A (pt) 2004-10-13

Family

ID=9922207

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212574-9A BR0212574A (pt) 2001-09-17 2002-09-17 Método de purificação de polipeptìdeo

Country Status (19)

Country Link
US (1) US20050070690A1 (pt)
EP (1) EP1427751A2 (pt)
JP (1) JP2005514914A (pt)
KR (1) KR20040047836A (pt)
CN (1) CN1564827A (pt)
AU (1) AU2002324207B2 (pt)
BR (1) BR0212574A (pt)
CA (1) CA2460706A1 (pt)
GB (1) GB0122400D0 (pt)
HR (1) HRPK20040339B3 (pt)
HU (1) HUP0400981A3 (pt)
IL (1) IL160912A0 (pt)
IS (1) IS7183A (pt)
MX (1) MXPA04002373A (pt)
NO (1) NO20041563L (pt)
NZ (1) NZ532331A (pt)
PL (1) PL369451A1 (pt)
RU (1) RU2004110939A (pt)
WO (1) WO2003025016A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096753A1 (en) * 1998-04-09 2003-05-22 Robertson Alan George Simpson Therapeutic agent
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
GB0020504D0 (en) * 2000-08-18 2000-10-11 Univ Bristol Therapeutic method
GB201308738D0 (en) * 2013-05-15 2013-06-26 Polytherics Ltd Novel polymer conjugates
JP2020026397A (ja) * 2018-08-09 2020-02-20 国立大学法人 岡山大学 TrkBアンタゴニストを含む医薬組成物
WO2025062271A1 (en) * 2023-09-19 2025-03-27 Signorile Pietro Giulio Antibodies against endometriosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166763C (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US5877016A (en) * 1994-03-18 1999-03-02 Genentech, Inc. Human trk receptors and neurotrophic factor inhibitors
US5844092A (en) * 1994-03-18 1998-12-01 Genentech, Inc. Human TRK receptors and neurotrophic factor inhibitors
CA2271950A1 (en) * 1996-11-22 1998-05-28 Sugen, Inc. Receptor tyrosine kinase genes
US20030096753A1 (en) * 1998-04-09 2003-05-22 Robertson Alan George Simpson Therapeutic agent
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
GB0020504D0 (en) * 2000-08-18 2000-10-11 Univ Bristol Therapeutic method

Also Published As

Publication number Publication date
HUP0400981A3 (en) 2006-01-30
GB0122400D0 (en) 2001-11-07
MXPA04002373A (es) 2004-11-22
IL160912A0 (en) 2004-08-31
EP1427751A2 (en) 2004-06-16
IS7183A (is) 2004-03-16
HUP0400981A2 (hu) 2005-02-28
NO20041563L (no) 2004-04-16
WO2003025016A3 (en) 2003-07-03
AU2002324207B2 (en) 2007-10-18
CN1564827A (zh) 2005-01-12
KR20040047836A (ko) 2004-06-05
CA2460706A1 (en) 2003-03-27
PL369451A1 (en) 2005-04-18
HRPK20040339B3 (en) 2006-02-28
RU2004110939A (ru) 2005-05-27
HRP20040339A2 (en) 2004-10-31
US20050070690A1 (en) 2005-03-31
JP2005514914A (ja) 2005-05-26
NZ532331A (en) 2005-10-28
WO2003025016A2 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
Wright et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells
WO2004020404A3 (en) Modified transferin-antibody fusion proteins
BR0207325A (pt) Métodos terapêuticos para doenças associadas com expressão diminuìda de gene de aop-1 ou aop-1
BR0212256A (pt) Proteìnas de fusão de transferrina modificadas
DK1129190T3 (da) Human TSLP DNA og polypeptider
WO2003076592A3 (en) Novel method for delivery and intracellular synthesis of sirna molecules
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
ES2085993T3 (es) Proteina asociada a la pancreatitis aguda, medios para el diagnostico de la pancreatitis aguda.
WO1997024436A3 (en) Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
NO20042173L (no) Fremgangsmate for fremstilling av rekombinant polypeptid
DK1430133T3 (da) En oplöselig Toll-lignende receptor
BR9306109A (pt) Gene e grupo de genes isolado e purifcado proteína com elevado peso molecular proteína com elevado peso molecular isolada e purificade conjugado e peptideo sintético
WO2003025016A3 (en) Trk polypeptide purification method
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
DE69125381D1 (de) Proteinstruktur des pflanzlichen toxins gelonin
ATE397662T1 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
WO2002004487A3 (de) Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
AU6308801A (en) Mu-1, member of the cytokine receptor family
WO1996023884A3 (en) Human peroxisome proliferator activated receptors
ATE403007T1 (de) Rekombinantes mva mit der fähigkeit zur expression von hcv struktur-antigenen
WO2000059942A3 (en) Human obesity protein binding protrein-2 homolog and uses thereof
WO2002006464A3 (en) Large scale expression and purification of recombinant proteins
WO2006049983A3 (en) Peptide yy modified transferrin fusion proteins
AU2003226907A8 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
WO2004053052A3 (en) HUMAN RECOMBINANT ENDOOLIGOPEPTIDASE A (hEOPA)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.